Korean J Pathol.  2010 Apr;44(2):125-131.

Lyn Expression in Osteoblastic Osteosarcoma Tissues and Its Correlation with Clinicopathologic Factors

• Jin MS
• Khang SK
• Kim MS
• Choi HS
• Lee JE
• Kim KH
• Jeon DG
• Koh JS

Abstract

BACKGROUND
The Src family kinases (SFKs) are involved in multiple aspects of tumorigenesis, such as, proliferation, migration, and angiogenesis, and are involved in the generation and progression of many types of tumors. Furthermore, dasatinib, a general SFKs inhibitor was recently approved for use in chronic myeloid leukemia. This study was performed to evaluate the expression of Lyn, a member of the SFKs, in osteosarcoma tissues.
METHODS
One hundred and sixteen patients with osteoblastic osteosarcoma were selected for Lyn expression analysis. The correlation between Lyn expression in tumor sections and patients' clinicopathologic characteristics and the prognostic significance of Lyn expression were evaluated.
RESULTS
Lyn was found to be expressed in 52 of the 116 patients (44.8%), and Lyn positive tumor was found to be significantly associated with a lytic tumor pattern on plain radiographs (p = 0.04). Furthermore, those positive for Lyn showed longer metastasis free survival (5-year metastasis free survival, 65.2% for Lyn positive and 46.8% for Lyn negative; p = 0.06), though this was only marginally significant.
CONCLUSIONS
Lyn was found to be overexpressed in osteosarcoma tissues, and this overexpression was found to be correlated with osteolysis.

Keyword

Osteosarcoma; Lyn protein-tyrosine kinase; Immunohistochemistry

MeSH Terms

Cell Transformation, Neoplastic
Humans
Immunohistochemistry
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Neoplasm Metastasis
Osteoblasts
Osteolysis
Osteosarcoma
Pyrimidines
src-Family Kinases
Thiazoles
Dasatinib
Pyrimidines
Thiazoles
src-Family Kinases